T cell receptor convergence is an indicator of antigen-specific T cell response in cancer immunotherapies

Elife. 2022 Nov 9:11:e81952. doi: 10.7554/eLife.81952.

Abstract

T cells are potent at eliminating pathogens and playing a crucial role in the adaptive immune response. T cell receptor (TCR) convergence describes T cells that share identical TCRs with the same amino acid sequences but have different DNA sequences due to codon degeneracy. We conducted a systematic investigation of TCR convergence using single-cell immune profiling and bulk TCRβ-sequence (TCR-seq) data obtained from both mouse and human samples and uncovered a strong link between antigen-specificity and convergence. This association was stronger than T cell expansion, a putative indicator of antigen-specific T cells. By using flow-sorted tetramer+ single T cell data, we discovered that convergent T cells were enriched for a neoantigen-specific CD8+ effector phenotype in the tumor microenvironment. Moreover, TCR convergence demonstrated better prediction accuracy for immunotherapy response than the existing TCR repertoire indexes. In conclusion, convergent T cells are likely to be antigen-specific and might be a novel prognostic biomarker for anti-cancer immunotherapy.

Keywords: TCR convergence; TCR repertoire; computational biology; human; immunology; immunotherapy prognosis; inflammation; mouse; systems biology.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Amino Acid Sequence
  • Animals
  • Humans
  • Immunotherapy
  • Mice
  • Neoplasms* / therapy
  • Receptors, Antigen, T-Cell / metabolism
  • T-Lymphocytes*

Substances

  • Receptors, Antigen, T-Cell

Associated data

  • GEO/GSE178881
  • GEO/GSE156728